Status
Conditions
Treatments
About
In the hospice ward, there are lots of suffered hospital patients with multiple physical discomfort related to terminal disease. Investigators want to use an objective measure instrument to monitor the effects of complementary and alternative medicine and clinical symptoms. First, investigators use the Meridian Energy Analysis Device (MEAD) to measure the bilateral 12 Yuan points (primary points) of terminal hospice patients. It provides the prediction value between terminal disease and the change of different meridian energy. Besides, the meridian energy value maybe predict the survival period. Then, the intervention of complementary and alternative medicine can also monitor via MEAD.
Full description
In the hospice ward, there are lots of suffered hospital patients with multiple physical discomfort related to terminal disease. It may be caused by cancer or multiple kinds of organ failure. The terminal hospital patients have symptoms such as pain, dyspnea, fatigue, nausea, vomiting, poor appetite, constipation, ileus or edema..., etc. Investigators want to use an objective measure instrument to monitor the effects of complementary and alternative medicine.
First, investigators use the Meridian Energy Analysis Device (MEAD) to measure the bilateral 12 Yuan points (primary points) of terminal hospice patients (divided to cancer, multiple kinds of organ failure). It provides the prediction value between terminal disease and the change of different meridian energy. Besides, the meridian energy value maybe predict the survival period. Then, investigators use the intervention of complementary and alternative medicine (like infrared lamp and acupressure..., etc.) to improve the quality of life in the terminal hospice patients. Also, investigators will use the Meridian Energy Analysis Device, pain scale, vital signs and quality of life scale (SF-36) to evaluate the effects of complementary and alternative medicine.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
Primary purpose
Allocation
Interventional model
Masking
200 participants in 1 patient group
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal